News and Press Releases

Read Veristat news and press releases to learn about our CRO service growth, geographic expansion in Europe and Asia, biotechnology preferred partnerships and small CRO acquisitions.

Veristat Expands Its San Francisco Bay Area Operations: Opens New Office to Support Life...

HOLLISTON, MA – June 15, 2015 – Veristat, a full service Clinical Research Organization (CRO), announced today that it has opened a new...

Veristat Growth and Service Demand Drive Expansion: Veristat to Move Corporate Headquarters

Veristat will Move Corporate Headquarters to Southborough, MA This Summer

National Association of Professional Women Announces Cynthia Henderson, Executive Vice...

Cynthia Henderson is recognized as an NAPW VIP Woman of the Year for her outstanding leadership and commitment within her profession

Garden...

Veristat supports the battle against rare cancers by participating in the Cycle for Survival

For Immediate Release

Veristat and Molecular Templates Inc. enter into Preferred Provider Agreement for...

For Immediate Release

Veristat to Assist on Adaptive Enrichment Design Trial for Verastem’s Defactinib in...

Input Will Drive Trial Design for Lead Cancer Stem Cell-Targeting Program

September 10, 2013 - Veristat, a leading,...

Veristat’s Collaboration with Aegerion Contributes to FDA Approval of Juxtapid™

Veristat’s Strategic Guidance Contributes to Successful Approval of Aegerion’s Novel Drug Juxtapid

Variance Development Partners Makes a Growth Investment in Veristat

Investment Will Enable Veristat to Further Enhance its Market Leadership Position and Provide Resources for Growth

Veristat, a ...

Prev 4 5 6 7 8 Next